AM Best affirms rating of Pfizer captive

AM Best has affirmed the financial strength rating of A (excellent) and the long-term issuer credit rating of “a+” (excellent) of Vermont-domiciled Blue Whale Re Ltd. The outlook of these credit ratings is stable.

Blue Whale’s is the only captive for New York-domiciled Pfizer Inc., a global pharmaceutical company.

Subscribe to Ci Premium to continue reading

Captive Intelligence provides high-value information, industry analysis, exclusive interviews and business intelligence tools to professionals in the captive insurance market.

Start a FREE TRIAL now.

Or, view Membership Options and Group Discounts.

Already a subscriber? Log in here